Literature DB >> 23239469

Neuropathological findings in benign tremulous parkinsonism.

Marianna Selikhova1, Peter A Kempster, Tamas Revesz, Janice L Holton, Andrew J Lees.   

Abstract

Benign tremulous parkinsonism, a tremor dominant syndrome with a relatively slow rate of deterioration, is recognized by clinicians although its pathological basis is not well understood. A systematic review of Queen Square Brain Bank donors was carried out to determine the natural history and pathology of individuals who had tremor dominant parkinsonism with mild non-tremor components and minimal gait disability for at least 8 years. We identified 16 cases of pathologically proved benign tremulous Parkinson's disease (PD); another 5 individuals conformed to the definition but did not have the pathology of PD. Patients with verified benign tremulous PD had less severe neuronal loss in the substantia nigra than controls (χ(2): P = .003). Twelve of these had been correctly diagnosed with PD at their first neurological evaluation, whereas the other 4 were originally thought to have another tremor disorder. The only consistent distinguishing feature of the 5 pathologically disproved cases, who may have had either essential tremor with associated rest tremor or dystonic tremor, was a failure to develop unequivocal bradykinesia within a decade of onset of tremor at rest. Our findings support the existence of a distinct subgroup of benign tremulous PD. The slower rate of clinical progression correlates with less severe nigral cell loss at postmortem, although many of these patients transgress the benign tremulous parkinsonism definition by the final third of their disease course and develop the common features of advanced PD.
Copyright © 2012 Movement Disorders Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239469     DOI: 10.1002/mds.25220

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  27 in total

Review 1.  Essential pitfalls in "essential" tremor.

Authors:  Alberto J Espay; Anthony E Lang; Roberto Erro; Aristide Merola; Alfonso Fasano; Alfredo Berardelli; Kailash P Bhatia
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

2.  Motor subtype changes in early Parkinson's disease.

Authors:  Robert S Eisinger; Christopher W Hess; Daniel Martinez-Ramirez; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2017-07-21       Impact factor: 4.891

3.  Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.

Authors:  Valtteri Kaasinen; Maija Kinos; Juho Joutsa; Marko Seppänen; Tommi Noponen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

4.  Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.

Authors:  L Arie; Talia Herman; S Shema-Shiratzky; N Giladi; J M Hausdorff
Journal:  J Neurol       Date:  2017-09-06       Impact factor: 4.849

5.  Deep brain stimulation for levodopa-refractory benign tremulous parkinsonism.

Authors:  Takuya Konno; Owen A Ross; Robert E Wharen; Ryan J Uitti; Zbigniew K Wszolek
Journal:  Neurol Neurochir Pol       Date:  2016-06-24       Impact factor: 1.621

Review 6.  [The new tremor classification of the International Parkinson and Movement Disorder Society : Update on frequent tremors].

Authors:  F Gövert; J Becktepe; G Deuschl
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 7.  Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?

Authors:  Seyed-Mohammad Fereshtehnejad; Ronald B Postuma
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

8.  Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson's disease motor subtypes.

Authors:  Talia Herman; S Shema-Shiratzky; L Arie; N Giladi; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2018-02-15       Impact factor: 3.575

9.  The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review.

Authors:  Vanessa Pitz; Naveed Malek; Edward S Tobias; Katherine A Grosset; Steve Gentleman; Donald G Grosset
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

Review 10.  The motor prodromes of parkinson's disease: from bedside observation to large-scale application.

Authors:  C Simonet; A Schrag; A J Lees; A J Noyce
Journal:  J Neurol       Date:  2019-12-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.